Sponsored Research
Matthew Hirschey of Endocrinology has received an award from the Glenn Foundation for Medical Research for a project entitled "Glenn Award for Research in Biological Mechanisms of Aging." Total funding will be $60,000.
Deborah Muoio of Endocrinology has received a sub-award (5R02-DK110656-03) through the East Carolina University for a project entitled "Organic Cations and Mitochondrial Efficiency." Total funding will be $84,176.
L. Ebony Boulware of General Internal Medicine has received a sub-award (1R21-DK116115-01A1) through the University of North Carolina - Chapel Hill for a project entitled "Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Placement Prior to Hemodialysis Initiation." Total funding will be $105,419.
Rowena Dolor of General Internal Medicine has received a sub-award (1R01-AR071057-01A1) through the Oregon Health & Science University for a project entitled "A Community-based Assessment of Skin Care, Allergies and Eczema (CASCADE)." Total funding will be $89,926.
Nelson Chao of Hematologic Malignancies and Cellular Therapy has received a sub-award (5U19-AI067773-14) through the Columbia University for a project entitled "Development of CaMKK2 inhibitor drug for acute radiation syndrome." Total funding will be $356,300.
Harry Erba of Hematologic Malignancies and Cellular Therapy has received a sub-award (5U10-CA180888-05) through the Oregon Health & Science University for a project entitled "SWOG Network Group Operations Center of the NCTN." Total funding will be $21,247.
John Bartlett of Infectious Diseases has received a sub-award (1R25-TW011227-01) through the Muhimbili University of Health and Allied Sciences for a project entitled "Health Professionals Education Partnership Initiative - Tanzania." Total funding will be $124,918.
Vance Fowler of Infectious Diseases has received a sub-award (5U01-AI124319-03) through the Los Angeles Biomedical Research Institute for a project entitled "Systems Immunobiology of Antibiotic-Persistent MRSA Infections." Total funding will be $100,629.
Megan Reller of Infectious Diseases has received an award from the Thrasher Research Fund for a project entitled "Effectiveness of PCV-10 to reduce severe viral acute lower respiratory infection in Bangladesh." Total funding will be $437,704.
Sky Vanderburg (Mentor: Aimee Zaas) of Infectious Diseases has received an award from the Thrasher Research Fund for a project entitled "Acute Lower Respirator Tract with Lung Ultrasound." Total funding will be $26,750.
Megan McNamara of Medical Oncology has received an award from the Prostate Cancer Foundation for a project entitled "PCF Young Investigator Award." Total funding will be $75,000.
Kevin Oeffinger of Medical Oncology has received an award (2R01-CA134722-06A1) from the National Institutes of Health for a project entitled "EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer." Total funding will be $3,205,412.
Sarah Sammons of Medical Oncology has received a sub-award () through the Duke University for a project entitled "Phase II Multicenter Study of Durvalumab (MEDI4736) and Olaparib in PlatinumTreated Advanced Triple Negative Breast Cancer ¿ DORA." Total funding will be $337,256.
Jason Somarelli of Medical Oncology has received an award from the SeaWorld & Busch Gardens Conservation Fund for a project entitled "Bioengineering Plastic-Degrading Microbes To Eliminate Plastic Waste." Total funding will be $15,000.
David Murdoch of Pulmonary has received an award (3R01-GM123542-03S1) from the National Institutes of Health for a project entitled "Magnetically directed single cell transcriptome analysis in HIV latency." Total funding will be $91,675.
Loretta Que of Pulmonary has received an award from the American Lung Association for a project entitled "Trial of Roflumilast in Asthma Management (TRIM)."
John Reynolds of Pulmonary has received an award from the Washington University in St. Louis for a project entitled "ECP Management of BOS." Total funding will be $55,492.
Virginia Kraus of Rheumatology has received an award (1R01-AG054840-01A1) from the National Institutes of Health for a project entitled "Epigenetic Mechanisms Promoting Longevity." Total funding will be $3,405,794.
Jennifer Rogers of Rheumatology has received a sub-award () through the University of North Carolina - Chapel Hill for a project entitled "Cross Sectional and Longitudinal Studies of Immune Complexes in SLE." Total funding will be $11,208.
Industry-sponsored Clinical Trials
Pamela Douglas of Cardiology has received an award from HeartFlow, Inc. for a project entitled "PRECISE." Total funding will be $3,842,888.
Martin Moseley III of Cardiology has received an award from Cognition Therapeutics for a project entitled "Metabolomics Analysis of Human Clinical Trial Samples." Total funding will be $82,072.
Jonathan Piccini of Cardiology has received an award from American Heart Association for a project entitled "Get With The Guidelines Registry SOW#17." Total funding will be $743,729.
Thomas Povsic of Cardiology has received an award from Recardio, Inc for a project entitled "RECARDIO - REC-DUT-002." Total funding will be $165,576.
Tracy Wang of Cardiology has received an award from Boston Scientific Corporation for a project entitled "A-Fib and CHD: A Long-Term Perspective on the Need for Triple Antithrombotic Therapy." Total funding will be $111,185.
Tracy Wang of Cardiology has received an award from Pfizer, Inc. for a project entitled "Adult Immunization - CO-01." Total funding will be $2,500.
Manal Abdelmalek of Gastroenterology has received an award from Bristol-Myers Squibb Company for a project entitled "A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in adults with nonalcoholic steatohepatitis (NASH) and Stage 3 liver fibrosis." Total funding will be $249,960.
Manal Abdelmalek of Gastroenterology has received an award from Bristol-Myers Squibb Company for a project entitled "A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in adults with nonalcoholic steatohepatitis (NASH) and Compensated Liver Cirrhosis." Total funding will be $238,832.
Manal Abdelmalek of Gastroenterology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "Novartis LJC242A2201J." Total funding will be $48,398.
David Leiman of Gastroenterology has received an award from Ironwood Pharmaceuticals, Inc. for a project entitled "A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors." Total funding will be $53,360.
Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from ImmunoGen, Inc. for a project entitled "A phase 1, Multi-center, open-label study of IMGN632 administered intravenously in patients with relapsed/refractory CD123-positive acute myeloid leukemia and other CD123-positive hematologic mali." Total funding will be $232,126.
Cristina Gasparetto of Hematologic Malignancies and Cellular Therapy has received an award from AbbVie Inc. for a project entitled "A Phase 2, Open-label, Multicenter, Dose-Escalation and Expansion Study of Venetoclax in Combination with Pomalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma." Total funding will be $436,308.
Matthew McKinney of Hematologic Malignancies and Cellular Therapy has received an award from Pharmacyclics, Inc. for a project entitled "Phase 3 Study of Ibrutinib in Combination with Venetoclax in Subjects with Mantle Cell Lymphoma." Total funding will be $387,089.
David Rizzieri of Hematologic Malignancies and Cellular Therapy has received an award from AbbVie Inc. for a project entitled "Phase 1b Study of Venetoclax and Alvocidib in Patients with Relapsed/Refractory Acute Myeloid Leukemia." Total funding will be $513,884.
Michael Harrison of Medical Oncology has received an award from Pfizer, Inc. for a project entitled "A pilot study aimed at assesssing whether an adequate sample of the patient popuation of interest is available, evaluating the quality and completeness of available data, and quantifying the duration of follow-up care available in Duke's EMR.." Total funding will be $127,272.
Andrew Nixon of Medical Oncology has received an award from MedImmune, Inc. for a project entitled "Profiling the Adenosine Axis in Metastatic Colorectal Cancer." Total funding will be $182,981.
Tian Zhang of Medical Oncology has received an award from Incyte Corporation for a project entitled "A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination with Immune Therapies in Subjects with Advance Metastatic Malignancies." Total funding will be $20,104.